Recent Comments

Comment RSS

Gonadotropin News and Research RSS Feed - Gonadotropin News and Research

Gonadotropins are protein hormones secreted by gonadotrope cells of the pituitary gland of vertebrates.

Genetic sonogram improves accuracy of noninvasive prenatal screening and detection of Down syndrome

21. November 2009 00:02
The addition of a "genetic sonogram" maximizes the accuracy of non-invasive testing for Down syndrome, said a Baylor College of Medicine researcher who was lead author of a landmark study in the current issue of Obstetrics and Gynecology. [More]

EMEA's CHMP recommends approval of Merck's ELONVA

20. November 2009 08:52
Merck & Co., Inc. today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended approval of ELONVA® (corifollitropin alfa injection) as a treatment in controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program. [More]

Posted in: Drug Trial News | Women's Health News

Tags: , , , , , , , , ,

Gene therapy may hold promise for cryptorchid individuals risking infertility

18. November 2009 05:47
EGR4 is a master gene responsible for fertility in cryptorchidism. Is gene therapy going to replace surgery? [More]

Ipsen receives marketing authorization in France for its 6-month sustained-release formulation of Decapeptyl

13. November 2009 01:39
Ipsen, an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities (Agence Française de Sécurité Sanitaire des Produits de Santé, AFSSAPS) have today granted the marketing authorization to the 6-month sustained-release formulation of Decapeptyl® (triptorelin embonate 22.5 mg) for the treatment of locally advanced and metastatic prostate cancer. [More]

Comprehensive report on assisted reproductive technology

11. November 2009 04:07
Research and Markets (http://www.researchandmarkets.com/research/420ecc/competitor_analysi) has announced the addition of the "Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)" report to their offering. [More]

Posted in: Device / Technology News

Tags: , ,

Positive results from Celldex Therapeutics' Phase 1 studies of CDX-1307 cancer vaccine candidate

29. October 2009 11:31
Celldex Therapeutics, Inc. today announced positive results from Phase 1 studies of CDX-1307 in patients with advanced epithelial cancers, including breast, colon, bladder and pancreatic cancer. [More]

Interim study analysis comparing MENOPUR with rFSH in GnRH Antagonist IVF cycles

21. October 2009 05:16
Ferring Pharmaceuticals presented an interim study analysis indicating that MENOPUR® (menotropins for injection, USP) is effective in in vitro fertilization (IVF) cycles using a gonadotropin-releasing hormone (GnRH) antagonist. The results were presented in a poster at the 65th Annual Meeting of the American Society for Reproductive Medicine (ASRM) in Atlanta, October 17-21, 2009. [More]

Co-promotion agreement to promote Prosed DS to urologists and retail pharmacists

15. October 2009 03:12
Timm Medical Technologies, Inc., a specialist Urology company, announced today its exclusive co-promotion agreement with Ferring Pharmaceuticals Inc., a Swiss-based biopharmaceutical company, for Prosed® DS (methenamine, phenyl salicylate, methylene blue, benzoic acid, hyoscyamine sulfate) in the United States. [More]

Debiopharm Group and Ipsen complete European decentralised registration of Decapeptyl

13. October 2009 02:09
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical Group, announced that the 6-month sustained-release formulation of Decapeptyl®1 (triptorelin embonate2 22.5 mg) successfully completed its European decentralised registration procedure involving nine countries: Germany (reference member state), France, Austria, Finland, Norway, Belgium, Denmark, Spain and The Netherlands. [More]

Reportlinker's medical review criteria guidelines for managing care

30. September 2009 08:03
Reportlinker Adds Medical Review Criteria Guidelines for Managing Care (8th ed. - 2009) [More]

Posted in: Healthcare News

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Report on the various segments of cancer treatment

25. September 2009 04:28
This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics - focuses on several segments for cancer treatment. The report covers both currently marketed and late stage development cancer products. Revenues for each current market segment were generated using dollar and unit sales for each product. [More]

Report on the market needs for current and emerging cancer diagnostic tests

22. September 2009 07:06
Research and Markets (http://www.researchandmarkets.com/research/f2ffa1/current_and_emergi) has announced the addition of the "Current and Emerging Cancer Diagnostic Tests: Emerging Assays and Companies Developing New Technologies and Products" report to their offering. [More]

Hormone therapy for treating prostate cancer is linked to heart problems

22. September 2009 06:21
Berlin, Germany: New research has found that hormone therapy used to treat men with advanced prostate cancer is associated with an increased chance of developing various heart problems. Some choices of therapy appear, however, to be less risky than others. [More]

New findings on how stress causes sexual dysfunction and infertility

16. June 2009 02:49
University of California, Berkeley, researchers have found what they think is a critical and, until now, missing piece of the puzzle about how stress causes sexual dysfunction and infertility. [More]

New device could track tumor's growth

13. May 2009 16:14
Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but only offer a snapshot of the tumor at a single moment in time. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.